• Citer

Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 Study

par Lonardi, Sara;André, Thierry;Wong, Ka Yeung Mark;Morse, Michael M.A.;McDermott, Ray;Hill, A.;Hendlisz, Alain ;Lenz, Heinz-Josef;Leach, Joseph;Moss, Rebecca R.A.;Cao, Alexander Z.A.;Ledeine, Jean Marie;Kopetz, Scott;Overman, Michael James
Référence Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 28, page (vi3)
Publication Publié, 2017-10

Article révisé par les pairs

• Accès en ligne
• Détails
• Statistiques

Titre:	Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 Study
Auteur:	Lonardi, Sara; André, Thierry; Wong, Ka Yeung Mark; Morse, Michael M.A.; McDermott, Ray; Hill, A.; Hendlisz, Alain; Lenz, Heinz-Josef; Leach, Joseph; Moss, Rebecca R.A.; Cao, Alexander Z.A.; Ledeine, Jean Marie; Kopetz, Scott; Overman, Michael James
Informations sur la publication:	Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 28, page (vi3)
Statut de publication:	Publié, 2017-10
Sujet CREF:	Cancérologie
	Hématologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1569-8041
	info:doi/10.1093/annonc/mdx422.001
	info:pii/S092375342034672X
	info:scp/85061297119
	info:pmid/31962658